Here are what the editors at HealthDay consider to be the most important developments in Critical Care for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
U.S. Could See 100,000 New Cases of COVID-19 Each Day, Fauci Says
TUESDAY, June 30, 2020 (HealthDay News) — Top U.S. infectious disease expert Anthony Fauci, M.D., warned Congress on Tuesday that COVID-19 infections could climb to 100,000 new cases daily unless ongoing outbreaks are contained.
Heart Rhythm Disorders Seen in Critically Ill COVID-19 Patients
TUESDAY, June 30, 2020 (HealthDay News) — Critically ill patients with COVID-19 are more likely to develop heart rhythm disorders than other hospitalized patients, according to a study published online June 22 in Heart Rhythm.
Latinos Have High Rate of Positivity for SARS-CoV-2
TUESDAY, June 30, 2020 (HealthDay News) — The rate of positivity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is over 40 percent for Latinos in the Baltimore-Washington D.C. region, according to a research letter published online June 18 in the Journal of the American Medical Association.
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
MONDAY, June 29, 2020 (HealthDay News) — Gilead Sciences, the maker of remdesivir, the first drug that showed promise in treating COVID-19 infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the company announced Monday.
CDC: U.S. COVID-19 Rates Much Higher Than Reported
MONDAY, June 29, 2020 (HealthDay News) — Actual COVID-19 infection rates in many areas of the United States are more than 10 times higher than reported rates, a U.S. Centers for Disease Control and Prevention study suggests.
The New York Times Article
More Information
NY Health Care Workers Report Distress Related to COVID-19 Care
MONDAY, June 29, 2020 (HealthDay News) — Many New York City health care workers are experiencing COVID-19-related psychological distress, especially nurses and advanced practice providers, according to a study published in the upcoming September-October issue of General Hospital Psychiatry.
Antibody Tests ID COVID-19 Two to Three Weeks After Symptoms
MONDAY, June 29, 2020 (HealthDay News) — Antibody testing may detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with sensitivity peaking at three weeks since symptom onset, according to a review published online June 25 in the Cochrane Library.
Factors Linked to Severe COVID-19 in Children Identified
MONDAY, June 29, 2020 (HealthDay News) — COVID-19 generally causes mild disease in children, with 8 percent of children requiring intensive care unit (ICU) admission, according to a study published online June 25 in The Lancet Child & Adolescent Health.
Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Autonomous Oxygen Titration Increases Proportion of Time in Normoxemia 
High-Dose Intravenous Vitamin C May Benefit Trauma Patients .jpg)
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest 
Protocol IDs Patients Who Can Be Treated While Seated in the ED 
Female Emergency Medicine Physicians Order More Tests, Admit More Patients 
Emergency Presentation of Cancer Common in Older Adults 
